OptimizeRx Corporation (OPRX)
NASDAQ: OPRX
· Real-Time Price · USD
18.70
0.36 (1.96%)
At close: Sep 26, 2025, 10:58 AM
1.96% (1D)
| Bid | 18.67 |
| Market Cap | 347.24M |
| Revenue (ttm) | 104.75M |
| Net Income (ttm) | -9.87M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -34.64 |
| Forward PE | 23.91 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 18.71 |
| Volume | 64,371 |
| Avg. Volume (20D) | 354,408.9 |
| Open | 18.48 |
| Previous Close | 18.34 |
| Day's Range | 18.48 - 18.92 |
| 52-Week Range | 3.78 - 19.47 |
| Beta | 1.20 |
| Ex-Dividend Date | n/a |
About OPRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OPRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsOptimizeRx Corporation is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+34.74%
OptimizeRx shares are trading higher after the com...
Unlock content with
Pro Subscription
1 month ago
+2.88%
OptimizeRx shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.
